Lihua Yu

As FogPharma’s Chief Data Officer, Dr. Lihua Yu is responsible for the development and implementation of data science strategy across all R&D functions and research programs, as well as establishing informatics and machine learning systems to power the design-make-test-predict cycle of the proprietary Helicon™ platform.

Dr. Yu brings over 20 years of experience and leadership in data science across computational biology, cancer genomics, research informatics, clinical genomics, real-world data, and evidence.

Prior to joining FogPharma, Dr. Yu was the President and Chief Data Science Officer at H3 Biomedicine Inc. and served in multiple roles during her near a decade tenure. At H3, she held overall responsibilities for the company’s R&D. As their Chief Data Science Officer, Dr. Yu was responsible for driving the expanded use of data and technology and leading the creation of a data science/cancer genomics/information-sharing engine supporting all phases of drug discovery and early clinical development. She led H3 during its transition from a drug discovery company to an early phase drug development company. Prior to H3, she was the Cancer Bioinformatics Leader at AstraZeneca and held roles of increasing responsibility from 2000-2011.

Dr. Yu earned her Ph.D. in Biomedical Engineering from Boston University working under Dr. Temple Smith, and her M.S. and B.S. in Biomedical Engineering from Tsinghua University, Beijing, China.